Doseology Sciences Inc. (MOOD.CN)
Doseology Sciences Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Kelowna, BC, CA. The stock last traded at $0.17, down 5.41% on the session, giving a market capitalisation of $1.4M. Its beta of -2.70 implies it has historically moved less than the broad market.
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Doseology Sciences Inc. is most often compared with the following Healthcare names: